logo

JNJ

Johnson & Johnson·NYSE
--
--(--)
--
--(--)
5.65 / 10
Netural

JNJ's fundamental analysis yields a mixed but selective rating (5.7/10). Strengths include an improved Days Sales Outstanding (56.73 days) and a low Cost of Sales ratio (32.12%), both in high-performing quartiles. However, Operating Revenue growth (6.05% YoY) and Asset-MV are weaker, tempering the outlook. The company's strong Interest Coverage ratio (44.38) and favorable Cash-MV and PB-ROE metrics support financial health. In summary, JNJ's fundamentals are solid but not spectacular, with room for improvement in top-line growth and asset efficiency.

Fundamental(5.65)SentimentTechnical

Analysis Checks(8/10)

Revenue-MV
Value-0.15
Score2/3
Weight16.88%
1M Return9.81%
Days sales outstanding
Value56.73
Score3/3
Weight1.79%
1M Return1.30%
Profit-MV
Value-0.31
Score3/3
Weight20.66%
1M Return12.21%
PB-ROE
Value1.51
Score3/3
Weight24.68%
1M Return12.29%
Income tax / Total profit (%)
Value17.73
Score2/3
Weight3.37%
1M Return2.06%
Interest coverage ratio (EBIT / Interest expense) (%)
Value44.38
Score2/3
Weight-0.86%
1M Return-0.66%
Operating revenue (YoY growth rate %)
Value6.05
Score1/3
Weight-0.37%
1M Return-0.28%
Cost of sales ratio (%)
Value32.12
Score3/3
Weight1.05%
1M Return0.72%
Asset-MV
Value-0.53
Score1/3
Weight16.08%
1M Return8.51%
Cash-MV
Value0.15
Score3/3
Weight16.71%
1M Return9.70%
Is JNJ undervalued or overvalued?
  • JNJ scores 5.65/10 on fundamentals and holds a Fair valuation at present. Backed by its 0.00% ROE, 28.46% net margin, 21.57 P/E ratio, 7.29 P/B ratio, and 90.37% earnings growth, these metrics solidify its Netural investment rating.